Skip to main content
Premium Trial:

Request an Annual Quote

Roche, ABI Settle PCR Patent-Infringement Suit Against Bio-Rad

NEW YORK, Feb. 13 (GenomeWeb News) - Roche Molecular Diagnostics and Applied Biosystems have settled their PCR-based lawsuit with MJ Research, the companies said today.


Under the settlement, Bio-Rad, which acquired MJ Research in 2004, will make an undisclosed payment to Roche Diagnostics and ABI to settle all outstanding patent-infringement claims.


Applera and Roche Molecular Systems sued MJ Research in the US District Court for the District of Connecticut in June 1998. A jury decided in favor of Applera and Roche in 2004. Bio-Rad acquired MJ in August of that year.  


In September, Applera announced that the court had issued a permanent injunction prohibiting Bio-Rad from manufacturing, selling, or servicing infringing thermal cycler products in the US -- despite Bio-Rad's claim that the companies had settled the suit on Aug. 29.


Two months later, the court denied a motion from MJ to "enforce" the settlement agreement, and Bio-Rad said that it planned to appeal the court's decision.


Roche Diagnostics and ABI said today that the court rejected all challenges to the enforceability of Roche's PCR patents and its licensing program.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.